Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema PACBIO

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
22.04.PacBio moved to Neutral at JPMorgan after guidance cut106
17.04.PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays49
16.04.S&P 500 Edges Lower; PacBio Shares Plunge68
16.04.PacBio plots budget cuts after DNA sequencing revenue shortfalls108
16.04.PacBio falls after issuing guidance below expectations245
16.04.Pacific Biosciences of California, Inc.: PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance315Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 - $75 Million Q1 2024 Earnings Conference Call Scheduled for May 9, 2024 MENLO PARK, Calif., April 16, 2024 /PRNewswire/...
► Artikel lesen
03.04.Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now126
22.03.Pacific Biosciences of California, Inc.: PacBio Grants Equity Incentive Award to New Employee415MENLO PARK, Calif., March 22, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee...
► Artikel lesen
13.03.PacBio's (PACB) New Panel to Aid Its Clinical Research Solution16
12.03.PacBio unveils gene panel for neurological disease study7
12.03.Pacific Biosciences of California, Inc.: PacBio Announces PureTarget Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions149HiFi Long-Read Sequencing Panel Supports Comprehensive Analysis of 20 Genes Associated With Neurological Disease MENLO PARK, Calif., March 12, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading...
► Artikel lesen
16.02.Earnings call: PacBio sees robust growth with 113% revenue surge in Q468
15.02.Pacific Biosciences of California, Inc.: PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results225MENLO PARK, Calif., Feb. 15, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2023. Fourth quarter results Revenue...
► Artikel lesen
06.02.PacBio's (PACB) New Kits to Boost Its Revio Sequencing System7
05.02.Pacific Biosciences of California, Inc.: PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale294New Library Preparation Solutions Offer Never Before Achieved Scale for the Revio Sequencing System MENLO PARK, Calif., Feb. 5, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of...
► Artikel lesen
16.01.PacBio's (PACB) New PanDNA Kit Ready to Boost DNA Extraction5
11.01.JPM24: PacBio puts up 56% annual growth after 2023's long- and short-read DNA sequencer launches10
10.01.Novogene Bolsters Global Presence with Expanded PacBio Revio Fleet, Advancing Long-Read Sequencing Applications578SINGAPORE, Jan. 10, 2024 /PRNewswire/ -- Novogene further expands its long-read sequencing capacity with the acquisition of six additional PacBio Revio sequencers, augmenting its fleet of...
► Artikel lesen
09.01.PacBio (PACB) Preliminary Q4 Revenues Boosted by Revio Sales4
08.01.PacBio reports prelim Q4 revenue $58.4M, shares fall19
Seite:  Weiter >>